Corporate News

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces its audited final results for the year ended 31 December 2024.

Download To view a full version of the results in  PDF format  click here

 

Financial Highlights

• Revenue of £3.6m (2023: £11.0m)
• Adjusted EBITDA loss of £1.93m (2023: £1.27m)
• VAT reclaim of £0.2m recognised in current period
• Cash balance at year end of £5.47m (2023: £7.75m)

 

Commercial and operational highlights

• Ongoing strong strategic relationship with Boots
• Unit sales of wellness tests up 92% on prior year – whilst positive long-term growth potential, this category remains in its infancy with awareness raising a key future priority
• Phlebotomy kit registered and operations in place for launch of service
• Distribution agreement for Heart Health self-test (“PocDoc”) which listed on www.boots.com in April 2025
• End-user sales of COVID LFTs continue to reduce
• Continued investment in the MHC digital platform providing strong ongoing digital capability
• Achievement of ISO 13485 and ISO 27001 certifications

 

The full Group Annual Report and Audited Financial Statements will be posted to shareholders today and will also be available shortly at https://investors.myhealthchecked.com/investors/annual-interim-reports

Commenting on Outlook Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said:

“Although sales of wellness tests in the current year to date have increased by approximately 62% over the comparable period in the prior year, demand for COVID LFTs by end users has continued to reduce. Despite tight cost controls the loss for H1 of the current year is therefore expected to be broadly comparable to the prior year. However, we will continue to drive towards long-term growth in consumer wellness testing. 

“As an organisation with deep retail product knowledge, the board recognizes the importance of partnerships with trusted retail brands, with the key to long-term profitable growth embedded in the end-to-end customer journey, which firmly places testing as part of a wider service and product offering and builds a longer-term relationship with the end customer. We are confident that our ongoing relationship with Boots will continue, and we expect our digital platform will be used to underpin communications with customers regarding testing services. Our digital platform is able to integrate a wide portfolio of products and is a critical enabler in the delivery of higher margin services in the rest of the consumer wellness value chain, and we will continue to explore potential opportunities and strategic partnerships with UK retailers and digital retail outlets."

Publication of Annual Report & Audit Financial Statement (“Annual Report”) & Notice of Annual General Meeting

The Annual Report and Audited Financial Statements will be posted to shareholders today. The Annual General Meeting (“AGM”) will be held at 12.30 p.m. on 31 July 2025 in the Castle Room at The Maltings, East Tyndall Street, Cardiff, CF24 5EA. Only registered shareholders are entitled to attend the AGM. Any shareholders who wish to attend the meeting should email [email protected] with their proof of shareholding to register for the meeting.

 

The Annual Report and Notice of AGM will be available online shortly here:

https://investors.myhealthchecked.com/

 

 

For further information contact:

MyHealthChecked PLC	www.myhealthchecked.com
Penny McCormick, Chief Executive Officer	via Walbrook PR
SPARK Advisory Partners Limited (NOMAD)	Tel: +44 (0)20 3368 3550
Neil Baldwin / Jade Bayat
Dowgate Capital Limited (Broker)	Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Alice Woodings	Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.